During the initial stages of this program1-3), we discovered that 1-N-(higher-acyl)-3"-N-substituted kanamycin A derivatives exhibited the remarkable antiviral activity against not only herpes simplex virus type I Miyama (HSV-I) but also influenza virus A/PR8 (influenza virus). Among these analogs, 1-N-palmitoyl-3"-N-(trifluoroacetyl)kanamycin A dihydrochloride (12) was found to show both antiviral activity and low cytotoxicity. Also, 1-N-palmitoylkanamycin A trihydrochloride (3), which was unsubstituted at the N-3" position, exhibited this excellent antiviral activity. However, the cytotoxicity on Vero cells of 3 was stronger than that of 12.
Based on these results, we have suggested that the introduction of higher-acyl group at the N-1 position of kanamycin A (1) was essential for emergence of the antiviral activity, and that the introduction of trifluoroacetyl group at the N-3" In the following report on this series, we attempt to study the effect of the position substituted by acyl group(s) in 1 on antiviral activity and cytotoxicity. We here report the synthesis, antiviral activity, and cytotoxicity of four positional isomers (3, 5, 8, 11) of N-palmitoylkanamycin A and three positional isomers (12, 14, 16) of Npalmitoyl-N'-(trifluoroacetyl)kanamycin A. The synthesis of four positional isomers (3, 5, 8, 11) of the N-palmitoylkanamycin A is summarized in Scheme 1.
3 was prepared as described in the previous Table 1 .
Assay Assays were carried out in confluent Vero cell cultures in multi-well trays (96 wells). The cell cultures were grown to confluence in EAGLE'S minimal essential medium supplemented with 5 % fetal bovine serum. HSV-I (Miyama) and influenza virus (A/PR8) were respectively grown in Vero cells and Madin and Darby canine kidiney cells (MDCK cells). The test compounds were dissolved in H2O*. The viral maximal cytopathic effect (CPE) was observed microscopically (X40). Antiviral activity was expressed as ID,, (50% inhibitory dose), that is, the concentration of the compound required to reduce viral CPE by 50 % (within the well), when it had reached completion (100 % cell destruction) in the control virus-infected cell cultures.
The cytotoxicity on Vero and MDCK cells was expressed as the minimum concentration of the compound which destroyed the cell monolayer. and influenza virus are summarized in Table 2 . All positional isomers (3, 5, 8, 11) of the Npalmitoylkanamycin A showed almost the same excellent antiviral activity against HSV-I (ID50 1.1'-2.8 pg/ml) and influenza virus (ID,, 18-32 pg/ml). The antiviral activity of these isomers against HSV-I was about 15 times more than that of virazole, but was about 15 times less than that of acyclovir. The antiviral activity against influenza virus was about 2 times less than that of virazole and amantadine. The cytotoxicity on Vero and MDCK cells of these isomers (3, 5, 8, 11) was almost the same level. From these results, the antiviral activity and the cytotoxicity were little affected by the position substituted by the palmitoyl group in kanamycin A. However, the cytotoxicity on Vero cell of these four isomers was stronger than that of 12.
Therefore, in the next step we attempted to study the antiviral activity and cytotoxicity of three positional isomers (12, 14, 16) of the Npalmitoyl-N'-(trifluoroacetyl)kanamycin A, because the cytotoxicity was found to be reduced by the introduction of trifluoroacetyl group into the N-palmitoylkanamycin A3).
The positional isomers (12, 14, 16) of the Npalmitoyl-N'-(trifluoroacetyl)kanamycin A exhibited almost the same excellent antiviral activity against HSV-I (ID50 1.4 2.6 erg/ml). The activity of these three isomers was about 15 times more than that of virazole, but was about 20 times less than that of acyclovir. The isomers (12, 16) also exhibited excellent antiviral activity against influenza virus (ID,, 16, 20 pg/ml), but the isomer (14) showed weaker activity against influenza virus than 12 and 16. Particularly, 12 exhibited the strongest activity against not only HSV-I but also influenza virus. The cytotoxicity on Vero and MDCK cells of these isomers (12, 14, 16) was almost the same level.
Thus, the antiviral activity of the N-palmitoyl-N'-(trifluoroacetyl)kanamycin A derivatives was almost similar to that of N-palmitoylkanamycin A derivatives. Moreover, the cytotoxicity on Vero cell of these isomers (12, 14, 16) was reduced by the introduction of trifluoroacetyl group, as expected. Particularly, the cytotoxicity on Vero cell (100 pig/ml) of the isomers (12, 14) was the weakest among the derivatives described above. The cytotoxicity on MDCK cell of 3, 5, 8, 11, 12, 14 and 16 was also more than 100 jig/ml.
Based on these results, we found that the position substituted by the palmitoyl group in kanamycin A was not necessarily significant factor to reveal the excellent antiviral activity and that the introduction of the trifluoroacetyl group into N-(higher-acyl)-kanamycin A derivatives was required for the reduction of cytotoxicity on Vero cell.
In vivo antiviral activity of their derivatives will be reported by other researchers elsewhere7).
Mechanism of the growth inhibition of virus is now under investigation.
